I'm LongbridgeAI, I can summarize articles.UBS analyst David Low maintained a Hold rating on Regis Healthcare Ltd. (REG) with a price target of A$5.95, citing his coverage of the healthcare sector. This follows a similar Hold from Jarden's Steven Wheen, while Jefferies recently kept a Buy rating on the stock.
In a report released today, David Low from UBS maintained a Hold rating on Regis Healthcare Ltd., with a price target of A$5.95.
Low covers the Healthcare sector, focusing on stocks such as CSL, Cochlear , and Regis Healthcare Ltd.. According to TipRanks, Low has an average return of 5.0% and a 52.24% success rate on recommended stocks.
In addition to UBS, Regis Healthcare Ltd. also received a Hold from Jarden’s Steven Wheen in a report issued on August 24. However, on August 25, Jefferies maintained a Buy rating on Regis Healthcare Ltd. (ASX: REG).